Aidoc Raises $110 Million in Series D

by Kay Aloha Villamor in June 17th, 2022

Aidoc, a Tel, Aviv, Israel- based leading provider of healthcare AI solutions, has announced that it raised a $110 million in Series D round investment, bringing its total funding to $250 million. 

The round was co-led by global growth investors TCV and Alpha Intelligence Capital (AIC), with participation from AIC's co-investor CDIB Capital, which will power the continued expansion of the Aidoc AI Care Platform. 

Company: Aidoc Medical Ltd.

Round: Series B

Funding Month: June 2022

Lead Investors: global growth investors TCV and Alpha Intelligence Capital (AIC)

Additional Investors: AIC's co-investor CDIB Capital

Company Website:

Software Category: AI Care Platform  

About the Company: Aidoc ( is the leading provider of artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance operational capabilities. Aidoc's AI Care Platform—the first of its kind—offers health systems a singular platform solution that works with physicians to manage the entire patient lifecycle—from diagnostic aid to consultation to suggested treatment paths to patient follow-up tools. In clinical studies, the Aidoc AI has proven to reduce the turnaround time, shorten the patient length of stay and improve patient outcomes.


Your cart